Escalation in Ukraine Conflict Hypersonic Missile Attack Stirs Market Geopolitical Concerns
DICKS Sporting Goods Reports First Quarter Financial Results
Paytm Block Deal Societe Generale Ghisallo Viridian Lead Buyers in Rs 964 Crore Stake Sale
Indias Strategic Pivot Modis Europe Trip Secures Tech and Defense Deals to Diversify Away from China and US Dependence
Hong Kongs Gold Hub Ambitions Get Boost with New Clearing System Set for July Launch
StateOwned Fuel Retailers Face Daily Losses of Nearly 600 Crore Despite Recent Price Hikes
CelSci Corporation CVM Q4 2024 Earnings Narrower Loss Beats Estimates Stock Slips
Teekay Corporation TK Q1 2026 Earnings Profitability Amid Market Volatility
SKE Q1 2026 Earnings Significant EPS Miss Amid Exploration Stage Operations
Thermo Fisher Scientific Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Pullback
OSS Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally
Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds
Sprott Focus Trust Inc FUND Edges Higher as Precious Metals Fund Holds Near Key Support
Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels
Barrick Mining B Surges 265 Bullish Momentum Testing Key Resistance Levels
First Trust Senior Floating Rate Income Fund II FCT Edges Higher as Floating Rate Exposure Provides Stability
Synopsys SNPS Declines 158 as Shares Approach Critical Support Level
BETRW Warrants Plunge 1579 as Support Level Nears Critical Test
PLUS THERAPEUTICS PSTV Slips 316 as Shares Test Key Support Amid Biotech Jitters
Penguin Solutions Inc PENG Rallies 327 as Buyers Test Critical Resistance Near 577
INNOVATE Corp VATE Gains 374 as Price Approaches Key Resistance Level
John B Sanfilippo Son JBSS Edges Higher as Stock Holds Above Key Support
Manhattan Associates MANH Rallies 3 as Stock Approaches Key Resistance Level
AIDriven NBFCs Reshaping Indias Credit Landscape with Intelligent Lending
TXO Partners Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Challenges
Janux Therapeutics JANX Edges Higher as Stock Tests Key Support Zone